[1]王艺晓,邱涛,朱宝立,等.CD4/CD8比值对艾滋病患者预后评估的重要作用[J].医学研究与战创伤救治(原医学研究生学报),2025,38(01):97-101.[doi:10.16571/j.cnki.2097-2768.2025.01.016]
　WANG Yixiao,QIU Tao,ZHU Baoli,et al.The important role of CD4/CD8 ratio in the prognosis assessment of AIDS patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2025,38(01):97-101.[doi:10.16571/j.cnki.2097-2768.2025.01.016]

点击复制

CD4/CD8比值对艾滋病患者预后评估的重要作用()

分享到62.8K

参考文献/References:

［1］ Ingle SM，May MT，Gill MJ，et al.Impact of risk factors for specif?ic causes of death in the first and subsequent years of antiretrovi?ral therapy among HIV - infected patients［J］. Clin Infect Dis，2014，59（2）: 287-297.［2］ Martínez-Sanz J，Díaz-?lvarez J，Rosas M，et al.Expanding HIVclinical monitoring: the role of CD4，CD8，and CD4/CD8 ratio inpredicting non-AIDS events［J］.EBio Med，2023，95: 104773.［3］ 张之，胡海洋，葛尤，等.艾滋病病毒血浆控制者外周血淋巴细胞亚群分析［J］.医学研究生学报，2020，33（10）:1051-1055.［4］ Lu W，Mehraj V，Vyboh K，et al.CD4:CD8 ratio as a frontiermarker for clinical outcome，immune dysfunction and viral reser?voir size in virologically suppressed HIV?positive patients［J］.JInt AIDS Soc，2015，18（1）: 20052.［5］ Serrano-Villar S，Wu K，Hunt PW，et al.Predictive value of CD8+T cell and CD4/CD8 ratio at two years of successful ART in therisk of AIDS and non-AIDS events［J］. EBio Med，2022，80:104072.［6］ Okhai H，Vivancos-Gallego MJ，Hill T，et al.CD4+:CD8+ T CellRatio Normalization and the Development of AIDS Events inPeople with HIV Starting Antiretroviral Therapy［J］.AIDS ResHum Retroviruses，2020，36（10）: 808-816.［7］ Ma J，Wang G，Zhu X，et al.Combining CD4 count，CD8 countand CD4/CD8 ratio to predict risk of mortality among HIV-posi?tive adults after therapy: a group-based multi-trajectory analysis［J］.Front Immunol，2023，14: 1269650.［8］ Serrano-Villar S，Deeks SG.CD4/CD8 ratio: an emerging bio?marker for HIV［J］.Lancet HIV，2015，2（3）: e76-77.［9］ Obeagu EI，Obeagu GU. Utilization of immunological ratios inHIV:Implications for monitoring and therapeutic strategies［J］.Medicine（Baltimore），2024，103（9）: e37354.［10］ Wolday D，Legesse D，Kebede Y，et al.Immune recovery in HIV-1 infected patients with sustained viral suppression under longtermantiretroviral therapy in Ethiopia［J］.PloS One，2020，15（10）: e0240880.［11］ Zhang W，Ruan L.Recent advances in poor HIV immune recon?stitution: what will the future look like?［J］Front Microbiol，2023，14: 1236460.［12］ 仇思婕，陈玉宏，陈国清.2020年盐城市新发现HIV-1抗体阳性者WB带型与CD4/CD8淋巴细胞计数结果分析［J］.江苏预防医学，2022，33（4）: 425-427.［13］ Sar?gül Y?ld?r?m F，Candevir A，Akhan S，et al.Comparison of Im?munological and Virological Recovery with Rapid，Early，andLate Start of Antiretroviral Treatment in Naive Plwh: Real-WorldData［J］.Int J Gen Med，2023，16: 1867-1877. ［14］ Serrano-Villar S，Sainz T，Lee SA，et al.HIV-Infected Individualswith Low CD4/CD8 Ratio despite Effective Antiretroviral Thera?py Exhibit Altered T Cell Subsets，Heightened CD8+T Cell Acti?vation，and Increased Risk of Non-AIDS Morbidity and Mortality［J］.PLoS Pathog，2014，10（5）: e1004078.［15］ Li CX，Li YY，He LP，et al.The predictive role of CD4+ cell countand CD4 / CD8 ratio in immune reconstitution outcome amongHIV / AIDS patients receiving antiretroviral therapy: an eightyearobservationinChina［J］.BMCImmunol，2019，20（1）:31.［16］ Grinsztejn E，Cardoso SW，Velasque L，et al.Impact of latent M.tuberculosis infection treatment on time to CD4/CD8 recovery inacute，recent and chronic HIV infection.［J］.J Acquir ImmuneDefic Syndr，2023，94（4）: 355-363.［17］ Sponaugle A，Weideman AMK，Ranek J，et al.Dominant CD4+ Tcell receptors remain stable throughout antiretroviral therapy-me?diated immune restoration in people with HIV［J］.Cell Rep Med，2023，4（11）: 101268.［18］ Mussini C，Lorenzini P，Cozzi-Lepri A，et al.CD4/CD8 ratio nor?malisation and non-AIDS-related events in individuals with HIVwho achieve viral load suppression with antiretroviral therapy:anobservationalcohortstudy［J］.LancetHIV，2015，2（3）:e98-106.［19］ 许文，陈威巍.CD56bright自然杀伤细胞亚群在人免疫缺陷病毒/丙型肝炎病毒共感染中的研究进展［J］.医学研究生学报，2012，25（1）: 103-106.［20］ d?Ettorre G，Ceccarelli G，Serafino S，et al.Dominant enrichmentof phenotypically activated CD38（+）HLA-DR（+）CD8（+）Tcells，rather than CD38（+）HLA-DR（+）CD4（+）T cells，inHIV/HCV coinfected patients on antiretroviral therapy［J］.J MedVirol，2016，88（8）: 1347-1356.［21］ Resino S，Galán I，Bellón JM，et al.Characterizing the ImmuneSystem After Long-Term Undetectable Viral Load in HIV-1-In?fected Children［J］.J Clin Immunol，2003，23（4）: 279-289.［22］ Serrano-Villar S，Pérez-Elías MJ，Dronda F，et al.Increased riskof serious non-AIDS-related events in HIV-infected subjects onantiretroviral therapy associated with a low CD4/CD8 ratio［J］.PloS one，2014，9（1）: e85798.［23］ Trickey A，May MT，Schommers P，et al.CD4:CD8 Ratio andCD8 Count as Prognostic Markers for Mortality in Human Immu?nodeficiency Virus-Infected Patients on Antiretroviral Therapy:The Antiretroviral Therapy Cohort Collaboration（ART-CC）［J］.Clin Infect Dis，2017，65（6）: 959-966.［24］ Virseda-Berdices A，Martín-Escolano R，Berenguer J，et al.Plas?ma metabolomic profile is near-normal in people with HIV onlong-term suppressive antiretroviral therapy［J］.Front Cell InfectMicrobiol，2024，14: 1340610.［25］ Sainz T，Serrano-Villar S，Díaz L，et al.The CD4/CD8 ratio as amarker T-cell activation，senescence and activation/exhaustionin treated HIV-infected children and young adults［J］. AIDS，2013，27（9）: 1513-1516.［26］ Monteiro J，Batliwalla F，Ostrer H，et al.Shortened telomeres inclonally expanded CD28-CD8+ T cells imply a replicative historythat is distinct from their CD28+CD8+ counterparts［J］.J Immu?nol，1996，156（10）: 3587-3590.［27］ Effros RB，Allsopp R，Chiu CP，et al.Shortened telomeres in theexpanded CD28-CD8+ cell subset in HIV disease implicate rep?licative senescence in HIV pathogenesis［J］.AIDS，1996，10（8）:F17-22.［28］ Domínguez-Domínguez L，Rava M，Bisbal O，et al.Low CD4/CD8ratio is associated with increased morbidity and mortality in lateand non-late presenters: results from a multicentre cohort study，2004-2018［J］.BMC Infect Dis，2022，22（1）: 379.［29］ Ron R，Martínez-Sanz J，Herrera S，et al.CD4/CD8 ratio andCD8+T-cell count as prognostic markers for non-AIDS mortalityin people living with HIV.A systematic review and meta-analysis［J］.Front Immunol，2024，15: 1343124.［30］ Liu B，Li K，Li S，et al.The association between the CD4/CD8 ra?tio and surgical site infection risk among HIV-positive adults: in?sights from a China hospital［J］. Front Immunol，2023，14:1135725.［31］ Brochado-Kith O，Martinez I，Berenguer J，et al.Near normaliza?tion of peripheral blood markers in HIV-infected patients onlong-term suppressive antiretroviral therapy: a case-control study［J］.AIDS，2020，34（13）: 1891-1897.［32］ Torti C，Prosperi M，Motta D，et al.Factors influencing the nor?malization of CD4+ T-cell count，percentage and CD4+/CD8+ Tcellratio in HIV-infected patients on long-term suppressive anti?retroviral therapy［J］.Clin Microbiol Infect，2012，18（5）: 449-458.

相似文献/References: